Inspired by Son's Cancer Battle, Father Takes to the Ring for Charity

Adam Arrand's 20-year-old son Connor had just completed a six-year battle with lymphoma when Adam decided to follow in his footsteps - but not in a conventional way. Instead, the 41-year-old took on the gruelling Ultra White Collar Boxing (UWCB) training regime to raise money for Cancer Research UK. Adam, a full-time carer for his wife Caroline, participated in the charity bout at Village Hotel, Blackpool, and although he lost, he was proud of what he had achieved.

Key Takeaways:

  • Adam Arrand, a 41-year-old father, participated in the Ultra White Collar Boxing (UWCB) charity event to raise money for Cancer Research UK after his son Connor's six-year battle with lymphoma.
  • Adam, a full-time carer for his wife Caroline, trained for eight weeks with Impact Gym in Blackpool and raised £230 for Cancer Research UK.
  • The event was a showcase for participants who had honed their boxing skills during the free professional training program.
  • Participants like Adam are asked to sell tickets for the show and raise at least £50 for Cancer Research UK.
  • So far, Ultra Events has raised £27 million for Cancer Research UK through the UWCB program.
  • Adam was inspired by his son's strength during his cancer battle and felt the need to do something similar.
  • Adam said he enjoyed the experience and loved the sense of achievement he felt despite losing his bout.

Statistics:

  • £27 million: The total amount raised for Cancer Research UK through the Ultra White Collar Boxing (UWCB) program.
  • £230: The amount Adam Arrand raised for Cancer Research UK through his charity bout.
  • £50: The minimum amount participants are asked to raise for Cancer Research UK.
  • 20: The age of Adam Arrand's son Connor, who battled lymphoma for six years.
  • 41: The age of Adam Arrand, who participated in the charity event.
  • 6 years: The duration of Connor's battle with lymphoma.

Sources:

  • Blackpool Gazette
  • Ultra White Collar Boxing (UWCB)
  • Cancer Research UK